Table 1 Patient demographics and tumor characteristics
Number of patients | |
|---|---|
Median age, year (range) | 60 (46–81) |
Gender (%) | |
Male | 51 (85%) |
Female | 9 (15%) |
Tumor location (%) | |
Upper | 8 (13.3%) |
Middle | 44 (73.4%) |
Lower | 5 (8.3%) |
Mutiple | 3 (5%) |
Clinical stage (%) | |
IA | 1 (1.7%) |
IB | 3 (5%) |
IIA | 1 (1.7%) |
IIB | 23 (38.3%) |
IIIA | 20 (33.3%) |
IIIB | 5 (8.3%) |
IIIC | 7 (11.7%) |
Pathological stage (%) | |
IA | 2 (3.3%) |
IB | 7 (11.7%) |
IIA | 1 (1.7%) |
IIB | 13 (21.7%) |
IIIA | 12 (20.0%) |
IIIB | 10 (16.7%) |
IIIC | 10 (16.7%) |
PCR | 5 (8.3%) |
Histologic grade (%) | |
G1 | 8 (13.3%) |
G2 | 34 (56.7%) |
G3 | 17 (28.3%) |
G4 | 1 (1.7%) |
Operation approach (%) | |
Thoracotomy | 25 (41.7%) |
VATS | 35 (58.3%) |
Neoadjuvant | |
No | 46 (76.7%) |
CRT | 11 (18.3%) |
CT | 3 (5%) |
Intraoperative RLN injury (%) | |
Yes | 24 (40%) |
No | 36 (60%) |